These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24262506)

  • 1. Use of desmopressin acetate in severe hyponatremia in the intensive care unit.
    Rafat C; Schortgen F; Gaudry S; Bertrand F; Miguel-Montanes R; Labbé V; Ricard JD; Hajage D; Dreyfuss D
    Clin J Am Soc Nephrol; 2014 Feb; 9(2):229-37. PubMed ID: 24262506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes in Severe Hyponatremia Treated With and Without Desmopressin.
    MacMillan TE; Cavalcanti RB
    Am J Med; 2018 Mar; 131(3):317.e1-317.e10. PubMed ID: 29061503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia.
    Perianayagam A; Sterns RH; Silver SM; Grieff M; Mayo R; Hix J; Kouides R
    Clin J Am Soc Nephrol; 2008 Mar; 3(2):331-6. PubMed ID: 18235152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Desmopressin in Critically Ill Patients with Hyponatremia Requiring 3% Hypertonic Saline.
    Tran LK; Marino KK; DeGrado JR; Szumita PM; Dube KM
    Am J Med Sci; 2021 Jun; 361(6):711-717. PubMed ID: 33812910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmopressin acetate (DDAVP)-associated hyponatremia and brain damage: a case series.
    Achinger SG; Arieff AI; Kalantar-Zadeh K; Ayus JC
    Nephrol Dial Transplant; 2014 Dec; 29(12):2310-5. PubMed ID: 25107337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Desmopressin in the Management of Severe, Hypovolemic Hyponatremia: A Single-Center, Comparative Analysis.
    Ward FL; Tobe SW; Naimark DMJ
    Can J Kidney Health Dis; 2018; 5():2054358118761051. PubMed ID: 29593879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DDAVP to prevent rapid correction in hyponatremia.
    Goldszmidt MA; Iliescu EA
    Clin Nephrol; 2000 Mar; 53(3):226-9. PubMed ID: 10749304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmopressin to Prevent Rapid Sodium Correction in Severe Hyponatremia: A Systematic Review.
    MacMillan TE; Tang T; Cavalcanti RB
    Am J Med; 2015 Dec; 128(12):1362.e15-24. PubMed ID: 26031887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of a Standardized Sodium Protocol on Incidence and Outcome of Dysnatremias in Neurocritical Care.
    Spatenkova V; Bradac O; Skrabalek P
    J Neurol Surg A Cent Eur Neurosurg; 2015 Jul; 76(4):279-90. PubMed ID: 25539069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing overcorrection of hyponatraemia with desmopressin.
    Tomlin SC; Williams R; Riley S
    BMJ Case Rep; 2011 Nov; 2011():. PubMed ID: 22674100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derivation and Validation of a Novel Risk Score to Predict Overcorrection of Severe Hyponatremia: The Severe Hyponatremia Overcorrection Risk (SHOR) Score.
    Woodfine JD; Sood MM; MacMillan TE; Cavalcanti RB; van Walraven C
    Clin J Am Soc Nephrol; 2019 Jul; 14(7):975-982. PubMed ID: 31189541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of hyponatremia with desmopressin use for nocturnal polyuria.
    Choi EY; Park JS; Kim YT; Park SY; Kim GH
    Am J Nephrol; 2015; 41(3):183-90. PubMed ID: 25871541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative Use of Desmopressin for Treatment of Profound Hyponatremia in the Setting of Emergency Surgery: A Case Report.
    Watterworth BS; Noorani RJ
    A A Pract; 2018 Jul; 11(2):54-56. PubMed ID: 29634545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment and validation of a defined fluid restriction protocol in the use of subcutaneous desmopressin for children with inherited bleeding disorders.
    Mason JA; Robertson JD; McCosker J; Williams BA; Brown SA
    Haemophilia; 2016 Sep; 22(5):700-5. PubMed ID: 27385253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating desmopressin-induced hyponatremia: a case using hypertonic saline.
    Shirazian S; Ali N; Fishbane S
    Clin Nephrol; 2013 Nov; 80(5):385-7. PubMed ID: 22579272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective.
    Sterns RH; Cappuccio JD; Silver SM; Cohen EP
    J Am Soc Nephrol; 1994 Feb; 4(8):1522-30. PubMed ID: 8025225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Relowering of Serum Sodium Concentration Overcomes Disturbances in Consciousness during Hyponatremia Overcorrection and Prevents Osmotic Demyelination Syndrome.
    Ochiai H; Uenishi E
    Intern Med; 2018; 57(16):2353-2357. PubMed ID: 30111674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hyponatremia.
    Sterns RH; Hix JK; Silver S
    Curr Opin Nephrol Hypertens; 2010 Sep; 19(5):493-8. PubMed ID: 20539224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A woman with postoperative hyponatremia related to desmopressin acetate.
    Schreiber A; Kubitza S; Luft FC
    Am J Kidney Dis; 2004 Jul; 44(1):e3-6. PubMed ID: 15211455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of proactive versus reactive administration of desmopressin in severe symptomatic hyponatremia: a randomized controlled trial.
    Pakchotanon K; Kanjanasuphak N; Chuasuwan A; Gojaseni P; Chittinandana A
    Sci Rep; 2024 Mar; 14(1):7487. PubMed ID: 38553491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.